Product/Composition : Reditux Rituximab Injection
Pharmaceutical Form : Injection
Strength/Pack : 500mg

Reditux injection is used to treat several forms of non-lymphoma, Hodgkin’s either alone or in combination with other treatments. Reditux injections are also utilized in the treatment of chronic lymphocytic leukaemia in combination with other drugs. In people who have already been treated with a tumour necrosis factor (TNF) inhibitor, reditux injection is combined with methotrexate to treat the symptoms of rheumatoid arthritis. It attack cancer cells to treat various kinds of NHL and CLL. Rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and pemphigus vulgaris are also treated with Reditux injections, which limit the function of a portion of the immune system that can harm the joints, veins, and other blood vessels.